Mitochondria as novel mediators linking gut microbiota to atherosclerosis that is ameliorated by herbal medicine: A review
Atherosclerosis (AS) is the main cause of cardiovascular disease (CVD) and is characterized by endothelial damage, lipid deposition, and chronic inflammation. Gut microbiota plays an important role in the occurrence and development of AS by regulating host metabolism and immunity. As human mitochond...
Main Authors: | Yujuan Li, Shengjie Yang, Xiao Jin, Dan Li, Jing Lu, Xinyue Wang, Min Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1082817/full |
Similar Items
-
Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
by: Shengjie Yang, et al.
Published: (2021-07-01) -
A Bibliometric Analysis of Research on the Links Between Gut Microbiota and Atherosclerosis
by: Ya Wang, et al.
Published: (2022-07-01) -
Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites
by: Bin Xie, et al.
Published: (2022-09-01) -
Gut Microbiota in Hypertension and Atherosclerosis: A Review
by: Barbara J. H. Verhaar, et al.
Published: (2020-09-01) -
Characterization of gut microbiota in adults with coronary atherosclerosis
by: Yu Dong, et al.
Published: (2023-05-01)